BLRX   $2.3  3.60% Market Closed

BioLineRx Ltd.
Total Cash 40.06M
totalCashPerShare 0.033
EBITDA -33.08M
Total Debt 31.25M
quickRatio 1.438
currentRatio 1.609
Total Revenue 17.05M
debtToEquity 223.553
Revenue/Share 0.24
ROA -0.35229
ROE -1.71937
grossProfits
freeCashflow -15.81M
operatingCashflow -30.35M
earningsGrowth
revenueGrowth
grossMargins 0.64546996
ebitdaMargins -1.9403999
operatingMargins -1.07046
profitMargins -1.7667199
enterpriseValue 517.72M
forwardPE -1.1555263
floatShares 1.09B
sharesOutstanding 79.94M
sharesShort 621.39K
sharesShortPriorMonth 179.22K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.05%
Short Ratio help_outline 1.94%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 0.012
Price To Book help_outline 36.59
earningsQuarterlyGrowth
netIncomeToCommon -30.12M
trailingEps -0.45%
forwardEps -0.38%
enterpriseToEbitda -15.65
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.1 3Q 2024
institutionsCount 34
lastUpdated Nov. 6, 2024, 5:26 p.m.